Phase 1, pharmacokinetic (PK) and pharmacodynamic (PD) study of oral alvespimycin (A; KOS-1022; 17-DMAG): Two different schedules in patients with advanced malignancies
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: K. T. Flaherty, L. Gore, A. Avadhani, S. Leong, K. Harlacker, Z. Zhong, R. G. Johnson, A. L. Hannah, P. O’Dwyer, S. G. Eckhardt
Language: English
Topic: Heat shock proteins research
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2249448335